Walgreens and Freenome have entered a multi-year partnership to advance clinical studies on Freenome’s blood-based tests for early cancer detection. Walgreens will leverage its national presence, patient insights, recruitment technology, and local infrastructure to engage diverse patient populations in Freenome’s research program. The initial focus will be on recruiting patients for Freenome’s Sanderson Study, evaluating blood-based tests for multiple cancers, with Walgreens using targeted outreach methods for patient enrollment and follow-up. Approximately 8,000 participants are expected to be enrolled in the study through Walgreens’ clinical study partner network.
What You Should Know:
- Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer.
- Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to evaluate blood-based early detection tests for multiple cancers.
Sanderson Study Recruiting
Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to evaluate blood-based early detection tests for multiple cancers. Using Curebase’s platform, Walgreens will deliver targeted outreach to potentially eligible patients and caregivers of all backgrounds via text, email or in-person consultation at the pharmacy. After completing a pre-screen, eligible patients are invited to enroll in the study. Walgreens healthcare providers will then perform a single blood draw at one of the company’s clinical trial locations and conduct a telehealth patient follow-up one year after their participation. The Sanderson Study will enroll approximately 8,000 participants through its clinical study partner network, which includes Walgreens.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: HitConsultant